BE Therapeutics
Biotechnology Research • 
New York City Metropolitan Area, United States • 1-10 Employees
Company overview
| Headquarters | New York City Metropolitan Area, United States |
| Website | |
| NAICS | 541714 |
| Founded | 2023 |
| Employees | 1-10 |
| Socials |
Key Contact at BE Therapeutics
Philip Ashton-Rickardt
Managing Director And Chief Scientific Officer
BE Therapeutics Email Formats
BE Therapeutics uses 1 email format. The most common is {first name} (e.g., john@betherapeutics.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name} | john@betherapeutics.com | 100% |
About BE Therapeutics
What if we could restore brain function for the tens of millions of individuals who suffer from permanent brain damage? Strokes, traumas, neurodegeneration, and tumors can all cause permanent brain damage, but as of now there are no treatments that enable affected individuals to regain lost abilities. Consequently, they remain dependent on costly care for the rest of their lives. The aim of the Brain Repair program is to develop methods for replacing damaged brain tissue, enabling patients to regain lost function. The success of BE Therapeutics will bring relief to the millions of people world-wide suffering from permanent brain damage.
BE Therapeutics revenue & valuation
| Annual revenue | $513,330 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $1,700,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Employees by Department
BE Therapeutics has 2 employees across 2 departments.
Departments
Number of employees
France
Australia
United Arab EmiratesFrequently asked questions
4.8
40,000 users
